NASDAQ: VTRSViatris Inc Stock Ownership - Who owns Viatris?
Insider buying vs selling
Have Viatris Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Goff Corinne Le | Chief Commercial Officer | 2025-09-11 | 7,032 | $10.25 | $72.04kSell |
| Scott Andrew Smith | Chief Executive Officer | 2025-08-12 | 22,000 | $9.99 | $219.74kBuy |
| Scott Andrew Smith | Chief Executive Officer | 2025-05-12 | 60,000 | $8.94 | $536.28kBuy |
| Goff Corinne Le | Chief Commercial Officer | 2025-04-15 | 19,023 | $7.48 | $142.29kSell |
| Goff Corinne Le | Chief Commercial Officer | 2025-04-15 | 855 | $7.48 | $6.40kSell |
| Paul Campbell | Chief Accounting Officer and Corporate Controller | 2025-03-04 | 74,110 | $9.37 | $694.41kSell |
| Leo Frans Groothuis | Director | 2025-03-04 | 1,166 | $9.37 | $10.93kSell |
| Leo Frans Groothuis | Director | 2025-03-04 | 50 | $9.37 | $468.50Sell |
| Goff Corinne Le | Chief Commercial Officer | 2025-03-04 | 16,276 | $9.37 | $152.51kSell |
| Goff Corinne Le | Chief Commercial Officer | 2025-03-04 | 521 | $9.37 | $4.88kSell |
VTRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VTRS insiders and whales buy or sell their stock.
VTRS Shareholders
What type of owners hold Viatris Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 12.45% | 145,115,010 | $1.45B | Institution |
| Laboratories Abbott | 11.64% | 135,750,000 | $1.35B | Insider |
| Blackrock Inc | 7.11% | 82,861,248 | $826.96M | Institution |
| Price T Rowe Associates Inc | 6.76% | 78,772,616 | $786.15M | Institution |
| Davis Selected Advisers | 5.69% | 66,375,520 | $662.43M | Institution |
| Products Abbott | 5.38% | 62,782,018 | $626.56M | Insider |
| State Street Corp | 4.74% | 55,287,700 | $551.77M | Institution |
| Dimensional Fund Advisors LP | 2.68% | 31,263,397 | $312.01M | Institution |
| Geode Capital Management LLC | 2.68% | 31,226,220 | $311.64M | Institution |
| Invesco Ltd | 2.37% | 27,626,973 | $275.72M | Institution |
VTRS vs Pharmaceutical Stocks
Viatris Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.